Study Finds Increased Risk of Stroke in Elderly After COVID and High Dose/Adjuvanted Influenza Shots
On Jan. 13 2023, the U.S. Food and Drug Administration (FDA) and the U.S. Centers for U.S. Disease Control and Prevention (CDC)) issued a public statement regarding the identification of a preliminary safety signal for ischemic stroke among adults over the age of 65 that occurs between one to 21 days after receiving Pfizer/BioNTech’s monovalent […]
